Christina Furebring
Direttore operativo presso Strike Pharma AB
Profilo
Christina Furebring is currently the Deputy Director at Atlas Therapeutics AB and A Bioscience Incentive AB.
She is also the Chief Operations Officer at Strike Pharma AB since 2022.
Previously, she worked as the Senior Vice President-Preclinical Development at Alligator Bioscience AB.
Dr. Furebring holds a doctorate degree from the University of Lund.
Posizioni attive di Christina Furebring
| Società | Posizione | Inizio |
|---|---|---|
| A Bioscience Incentive AB | Corporate Officer/Principal | - |
Atlas Therapeutics AB
 Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013. | Corporate Officer/Principal | - |
Strike Pharma AB
 Strike Pharma AB Miscellaneous Commercial ServicesCommercial Services Strike Pharma AB is a Swedish company that specializes in developing therapeutic vaccines for solid tumors. The company is based in Uppsala, Sweden and was founded in 2020 by Pierre Dönnes and Sara Mangsbo. The company utilizes ADAC technology to create personalized immunotherapy for their patients. Mårten Winge has been the CEO of the company since 2021. | Direttore operativo | 01/01/2022 |
Precedenti posizioni note di Christina Furebring
| Società | Posizione | Fine |
|---|---|---|
| ALLIGATOR BIOSCIENCE AB | Corporate Officer/Principal | - |
Formazione di Christina Furebring
| University of Lund | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ALLIGATOR BIOSCIENCE AB | Health Technology |
| Aziende private | 3 |
|---|---|
| A Bioscience Incentive AB | |
Atlas Therapeutics AB
Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013. | Health Technology |
Strike Pharma AB
Strike Pharma AB Miscellaneous Commercial ServicesCommercial Services Strike Pharma AB is a Swedish company that specializes in developing therapeutic vaccines for solid tumors. The company is based in Uppsala, Sweden and was founded in 2020 by Pierre Dönnes and Sara Mangsbo. The company utilizes ADAC technology to create personalized immunotherapy for their patients. Mårten Winge has been the CEO of the company since 2021. | Commercial Services |
- Borsa valori
- Insiders
- Christina Furebring
